Factor VIII inhibitor bypass activity (FEIBA) for the reduction of transfusion in cardiac surgery: a randomized double-blind placebo-controlled pilot trial

摘要

Study design and decision algorithm to guide the management of bleeding diathesis after separation from cardiopulmonary bypass (CPB). FEIBA, factor VIII inhibitor bypass activity; FFPs, fresh-frozen plasma; PLT, platelet; PRBCs, packed red blood cells